CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ESOHISTO aims to transform the diagnosis and treatment of gastrointestinal cancers through advanced imaging technologies. By developing a novel endoscopic system that combines multiple imaging methods, it seeks to provide real-time, detailed insights into the cellular structure and biochemical processes of diseased tis…
ESOHISTO proposes a radically new scientific concept to revolutionize disease research, diagnosis and treatment by real-time imaging of 3D organization of diseased cells, cell-cell and cell-matrix interactions, and their biochemical events in large living human tissue/organs.
This transformative vision of 'in vivo histology and histochemistry' is not yet feasible for most human organs.
However, GI mucosa, the shallow lining of GI tract where many GI cancer originates, is a unique tissue to imple…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, BASINGSTOKE
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
France, Besancon
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
